EP Patent

EP0143524A1 — Two-part capsule

Assigned to Lilly Industries Ltd · Expires 1985-06-05 · 41y expired

What this patent protects

There is described a two part capsule composed of rigid material readily soluble when ingested, preferably gelatin, which capsule comprises a cap and body, both of which are of cylindrical form and roundedly closed at one end and open at the other, the body being telescoped withi…

USPTO Abstract

There is described a two part capsule composed of rigid material readily soluble when ingested, preferably gelatin, which capsule comprises a cap and body, both of which are of cylindrical form and roundedly closed at one end and open at the other, the body being telescoped within the cap to form a closed container, the relative lengths of the cap and body being such that only the closed rounded end of the body protrudes externally from the cap, the ratio of the length of the capsule to the diameter of the cap being in the range of from 2.5-3.5 to 1.

Drugs covered by this patent

Patent Metadata

Patent number
EP0143524A1
Jurisdiction
EP
Classification
—
Expires
1985-06-05
Drug substance claim
No
Drug product claim
No
Assignee
Lilly Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.